The speech Pacira seeks to punish is scientific debate," the American Society of Anesthesiologists argued in its court motion.

The court in Brussels also criticized the drug maker for a serious breach of its contract with the EU.

The law didn't generate a significant increase in the use of cheaper generics during the first year it went into effect.